Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × Chemoradiotherapy × Clear all

NCT07200154 2025-09-30

Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma